Can Bile Salt Export Pump Inhibition Testing in Drug Discovery and Development Reduce Liver Injury Risk? An International Transporter Consortium Perspective

Author:

Kenna J. Gerry1,Taskar Kunal S.2,Battista Christina3,Bourdet David L.4,Brouwer Kim L.R.5,Brouwer Kenneth R.6,Dai David7,Funk Christoph8,Hafey Michael J.9,Lai Yurong10,Maher Jonathan11,Pak Y. Anne12,Pedersen Jenny M.13,Polli Joseph W.14,Rodrigues A. David15,Watkins Paul B.16,Yang Kyunghee3,Yucha Robert W.17,

Affiliation:

1. Safer Medicines Trust; Kingsbridge UK

2. Mechanistic Safety and Disposition; IVIVT; GlaxoSmithKline; Ware Hertfordshire UK

3. DILIsym Services Inc., a Simulations Plus Company; Research Triangle Park North Carolina USA

4. Drug Metabolism and Pharmacokinetics; Theravance Biopharma; South San Francisco California USA

5. Division of Pharmacotherapy and Experimental Therapeutics; UNC Eshelman School of Pharmacy; University of North Carolina at Chapel Hill; Chapel Hill North Carolina USA

6. ADME-TOX; BioIVT; Durham North Carolina USA

7. Clinical Pharmacology; Research and Development Sciences; Agios Pharmaceuticals; Cambridge Massachusetts USA

8. Roche Pharmaceutical Research and Early Development; Pharmaceutical Sciences; Roche Innovation Center Basel; Basel Switzerland

9. Department of Pharmacokinetics, Pharmacodynamics, and Drug Metabolism; Merck & Co., Inc; Kenilworth New Jersey USA

10. Drug Metabolism; Gilead Sciences Inc.; Foster City California USA

11. Safety Assessment; Genentech; South San Francisco California USA

12. Lilly Research Laboratory; Lilly Corporate Center; Eli Lilly and Company; Indianapolis Indiana USA

13. Department of Neurobiology, Care Sciences and Society; Karolinska Institute; Novum Huddinge Sweden

14. Mechanistic Safety and Drug Disposition; GlaxoSmithKline; King of Prussia Pennsylvania USA

15. PDM; Medicine Design; Pfizer Inc.; Groton Connecticut USA

16. Institute for Drug Safety Sciences; UNC Eshelman School of Pharmacy; University of North Carolina; Chapel Hill North Carolina USA

17. Takeda Pharmaceuticals, Global Drug Metabolism and Pharmacokinetics; Cambridge Massachusetts USA

Funder

National Institute of General Medical Sciences

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3